#25-8 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 10.01.2025
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 10.01.2025 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 10.01.2025 Date 10.01.2025 Exchange transaction Buy Share class ALEX Amount 10 Average price/share 8,7500 EUR Highest
Nordea Bank Abp: Repurchase of own shares on 10.01.2025
Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares10.01.2025 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 10.01.2025 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average
Ghosts of Tabor Announces First-Ever Twitch Drops Event Coming January 24-27
Reading Time: 2 minutes MEDIA ALERT – Beyond Frames Entertainment and Combat Waffle Studios today announced that, in collaboration with Twitch, Ghosts of Tabor will host its first Twitch Drops event from 11 am EST on Friday, January 24 through 8 am EST on
Klaria signs license agreement for Sumatriptan Alginate film in Europe with CNX Therapeutics
Reading Time: 5 minutes Klaria Pharma Holding AB (publ) (“Klaria” or the “Company”) announces that the Company has signed a license agreement for Sumatriptan Alginate Film (the “Product”), a pharmaceutical product based on Klaria’s patented alginate films for fast and reliable administration via the oral mucosa,
Fitch Affirms Investment Grade Rating of ’BBB-’ for Heimstaden Bostad, Raised Outlook to Stable
Reading Time: < 1 minute Fitch affirms Heimstaden Bostad’s Long-Term Issuer Default rating (IDR) of ‘BBB-‘ and raises the Outlook to Stable from Negative. Co-CEO Christian Fladeland comments: “The stable outlook validates that Heimstaden Bostad continues to deliver on its base case performance which
Sobi’s full year 2024 revenue higher than previous estimate
Reading Time: 2 minutes Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today that revenue for the full year 2024 was higher than previous estimate. Full-year revenue was approximately SEK 26,000 M, representing approximately 19% growth at constant exchange rate (CER) (1). Adjusted EBITA margin (1,2)
ABAX disputes Greater Than’s claims in its entirety
Reading Time: < 1 minute Read original Larvik (Norway), January 10, 2025 – In reference to the press release of January 10th issued by Greater Than, accusing ABAX of infringing upon contractually regulated intellectual property (IP) rights, ABAX categorically refutes these allegations. ABAX find it
STENOCARE A/S announces guarantee commitments in ongoing rights issue
Reading Time: 3 minutes STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (“Stenocare” or the “Company”) announces that the Company has received a legally binding guarantee commitment of 2 mDKK from Exelity AB, securing approximately 9.9 percent of the total issue corresponding to approximately
Invitation to monthly digital events and presentations of quarterly report
Reading Time: < 1 minute Hamlet BioPharma is pleased to announce the continuation of the digital event series in the spring of 2025. These events provide participants a valuable opportunity to follow and discuss our drug development process and engage directly with our team during